Figure 2.
Succinylacetone excretion at increasing plasma NTBC levels. As NTBC blood levels increase, there is no significant difference in the mmol SUAC/mol creatinine excreted above an NTBC plasma level of 40 μmol/L (P > 0.05), supporting a therapeutic range of 40 to 60 μmol/L. There is significant difference in succinylacetone excretion below 40 μmol/L (P < 0.05)